Ascribe Bioscience

About:

Ascribe Bioscience develops products that enable farmers to combat crop pathogens without negative impacts on the environment.

Website: https://ascribebio.com/

Top Investors: National Science Foundation, Creative Destruction Lab (CDL), The Yield Lab, Ponderosa Ventures, Acre Venture Partners

Description:

Ascribe Bioscience develops products that enable farmers to combat crop pathogens without negative impacts on the environment. The company is currently developing a seed treatment product that acts by boosting crops’ natural defenses. Ascribe Bioscience was founded in 2017 and is headquartered in Ithaca, New York.

Total Funding Amount:

$7.16M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Ithaca, New York, United States

Founded Date:

2017-01-01

Founders:

Jay Farmer, Murli Manohar

Number of Employees:

1-10

Last Funding Date:

2022-08-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai